ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA

Christina Tsien; Stephanie Pugh; adam Dicker; Jeffrey Raizer; Martha Matuszak; Enrico Lallana; Jiayi Huang; ozer algan; Nicholas Taylor; Lorraine Portelance; John Villano; John T Hamm; Kevin S Oh; Arif N Ali; Michelle Kim; Scott Lindhorst; Minesh Mehta

doi:10.1093/neuonc/noz175.075

ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA

Christina Tsien, Stephanie Pugh, adam Dicker, Jeffrey Raizer, Martha Matuszak, Enrico Lallana, Jiayi Huang, ozer algan, Nicholas Taylor, Lorraine Portelance, John Villano, John T Hamm, Kevin S Oh, Arif N Ali, Michelle Kim, Scott Lindhorst, Minesh Mehta

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1093/neuonc/noz175.075
State	Published - Nov 11 2019
Event	Neuro-oncology - Duration: Nov 11 2019 → …

Conference

Conference	Neuro-oncology
Period	11/11/19 → …

Disciplines

Oncology
Internal Medicine
Medicine and Health Sciences

Access to Document

10.1093/neuonc/noz175.075License: Unspecified

Cite this

Tsien, C., Pugh, S., Dicker, A., Raizer, J., Matuszak, M., Lallana, E., Huang, J., algan, O., Taylor, N., Portelance, L., Villano, J., Hamm, J. T., Oh, K. S., Ali, A. N., Kim, M., Lindhorst, S., & Mehta, M. (2019). ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA. Neuro-oncology. https://doi.org/10.1093/neuonc/noz175.075

Tsien, C, Pugh, S, Dicker, A, Raizer, J, Matuszak, M, Lallana, E, Huang, J, algan, O, Taylor, N, Portelance, L, Villano, J, Hamm, JT, Oh, KS, Ali, AN, Kim, M, Lindhorst, S & Mehta, M 2019, 'ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA', Neuro-oncology, 11/11/19. https://doi.org/10.1093/neuonc/noz175.075

@conference{9bcbfcbb4f1248f4af742aa675738f1b,

title = "ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA",

author = "Christina Tsien and Stephanie Pugh and adam Dicker and Jeffrey Raizer and Martha Matuszak and Enrico Lallana and Jiayi Huang and ozer algan and Nicholas Taylor and Lorraine Portelance and John Villano and Hamm, \{John T\} and Oh, \{Kevin S\} and Ali, \{Arif N\} and Michelle Kim and Scott Lindhorst and Minesh Mehta",

note = "You do not currently have access to this article. Subscription prices and ordering ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA - 24 Hours access; Neuro-oncology ; Conference date: 11-11-2019",

year = "2019",

month = nov,

day = "11",

doi = "10.1093/neuonc/noz175.075",

language = "American English",

}

TY - CONF

T1 - ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA

AU - Tsien, Christina

AU - Pugh, Stephanie

AU - Dicker, adam

AU - Raizer, Jeffrey

AU - Matuszak, Martha

AU - Lallana, Enrico

AU - Huang, Jiayi

AU - algan, ozer

AU - Taylor, Nicholas

AU - Portelance, Lorraine

AU - Villano, John

AU - Hamm, John T

AU - Oh, Kevin S

AU - Ali, Arif N

AU - Kim, Michelle

AU - Lindhorst, Scott

AU - Mehta, Minesh

N1 - You do not currently have access to this article. Subscription prices and ordering ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA - 24 Hours access

PY - 2019/11/11

Y1 - 2019/11/11

UR - https://academic.oup.com/neuro-oncology/article/21/Supplement_6/vi20/5620082

U2 - 10.1093/neuonc/noz175.075

DO - 10.1093/neuonc/noz175.075

M3 - Presentation

T2 - Neuro-oncology

Y2 - 11 November 2019

ER -

ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA

Conference

Disciplines

Access to Document

Other files and links

Cite this